SPRING BK PHARMACEUTICALS IN - COM (SBPH)

CUSIP: 849431101

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM
Total 13F shares
7,021,963
Share change
+53,708
Total reported value
$72,911,047
Price per share
$10.39
Number of holders
55
Value change
+$78,167
Number of buys
29
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 849431101?
CUSIP 849431101 identifies SBPH - SPRING BK PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SPRING BK PHARMACEUTICALS IN - COM (SBPH) as of Q4 2018

As of 31 Dec 2018, SPRING BK PHARMACEUTICALS IN - COM (SBPH) was held by 55 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,021,963 shares. The largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., BVF INC/IL, BlackRock Inc., BAKER BROS. ADVISORS LP, Vanguard Group Inc, JENNISON ASSOCIATES LLC, TIEDEMANN ADVISORS, LLC, AXA, PARSONS CAPITAL MANAGEMENT INC/RI, and Sectoral Asset Management Inc. This page lists 55 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.